Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Triptorelin

Known as: triptorelina, pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2, TRIP 
A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
IMPORTANCE Whether the administration of luteinizing hormone-releasing hormone analogues (LHRHa) during chemotherapy is a… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Adjuvant therapy with an aromatase inhibitor improves outcomes, as compared with tamoxifen, in postmenopausal women… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE Chemotherapy-induced amenorrhea is a serious concern for women undergoing cancer therapy. This prospective randomized… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
CONTEXT Premenopausal patients with breast cancer are at high risk of premature ovarian failure induced by systemic treatments… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To examine and compare the efficacy and safety of GnRH agonist (GnRHa) vs. aromatase inhibitor in premenopausal women… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To compare the efficacy of Dienogest versus Decapeptyl at 3.75 mg as consolidation therapy for surgery in the treatment… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The signaling pathway through which LHRH acts in endometrial and ovarian cancers is distinct from that in the anterior pituitary… Expand
  • figure 1
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To confirm the value of a single dose of 3 mg of cetrorelix in preventing the occurrence of premature LH surges… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE The aim of the study was to evaluate the efficacy of antiandrogen therapy on overall survival and response in… Expand
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Safety and efficacy of a slow-release formulation of D-Trp-6-luteinising-hormone-releasing-hormone (D-Trp-6-LHRH) microcapsules… Expand
Is this relevant?